Chiudi

Aggiungi l'articolo in

Chiudi
Aggiunto

L’articolo è stato aggiunto alla lista dei desideri

Chiudi

Crea nuova lista

Health Technology Assessment: Using Biostatistics to Break the Barriers of Adopting New Medicines - Robert B. Hopkins MA MBA PhD,Ron Goeree MA - cover
Health Technology Assessment: Using Biostatistics to Break the Barriers of Adopting New Medicines - Robert B. Hopkins MA MBA PhD,Ron Goeree MA - cover
Dati e Statistiche
Wishlist Salvato in 0 liste dei desideri
Health Technology Assessment: Using Biostatistics to Break the Barriers of Adopting New Medicines
Disponibile in 5 giorni lavorativi
39,18 €
-5% 41,24 €
39,18 € 41,24 € -5%
Disp. in 5 gg lavorativi
Chiudi
Altri venditori
Prezzo e spese di spedizione
ibs
39,18 € Spedizione gratuita
disponibile in 5 giorni lavorativi disponibile in 5 giorni lavorativi
Info
Nuovo
Altri venditori
Prezzo e spese di spedizione
ibs
39,18 € Spedizione gratuita
disponibile in 5 giorni lavorativi disponibile in 5 giorni lavorativi
Info
Nuovo
Altri venditori
Prezzo e spese di spedizione
Chiudi

Tutti i formati ed edizioni

Chiudi
Health Technology Assessment: Using Biostatistics to Break the Barriers of Adopting New Medicines - Robert B. Hopkins MA MBA PhD,Ron Goeree MA - cover
Chiudi

Promo attive (0)

Descrizione


The term health technology refers to drugs, devices, and programs that can improve and extend quality of life. As decision-makers struggle to find ways to reduce costs while improving health care delivery, health technology assessments (HTA) provide the evidence required to make better-informed decisions. This is the first book that focuses on the statistical options of HTAs, to fully capture the value of health improvements along with their associated economic consequences. After reading the book, readers will better understand why some health technologies receive regulatory or reimbursement approval while others do not, what can be done to improve the chances of approval, as well as common shortcomings of submissions for drug and device reimbursement. The book begins by contrasting the differences between regulatory approval and reimbursement approval. Next, it reviews the principles and steps for conducting an HTA, including the reasons why different agencies will have a different focus for their scope in the HTA. Supplying an accessible introduction to the various statistical options for different methods in an HTA, the book identifies the links to regulatory and reimbursement decisions for each option. It highlights many of the methodological advances that have occurred since HTA research began, to provide researchers and decision-makers with a cutting-edge framework. It also details the logical basis for the methods along with simple instructions on how to conduct the various techniques. Both authors have considerable experience in generating evidence for submissions and reviewing submissions to decision-makers for funding. One of the authors has also received a nationally recognized lifetime achievement award in this area.
Leggi di più Leggi di meno

Dettagli

2021
Paperback / softback
276 p.
Testo in English
254 x 178 mm
453 gr.
9781032098715
Chiudi
Aggiunto

L'articolo è stato aggiunto al carrello

Chiudi

Aggiungi l'articolo in

Chiudi
Aggiunto

L’articolo è stato aggiunto alla lista dei desideri

Chiudi

Crea nuova lista

Chiudi

Chiudi

Siamo spiacenti si è verificato un errore imprevisto, la preghiamo di riprovare.

Chiudi

Verrai avvisato via email sulle novità di Nome Autore